Medical Expulsive Therapy Underused for Ureteral Stones

This article originally appeared here.
Share this content:
Medical Expulsive Therapy Underused for Ureteral Stones
Medical Expulsive Therapy Underused for Ureteral Stones

THURSDAY, April 21, 2016 (HealthDay News) -- For patients with ureteral stones, medical expulsive therapy remains underused, according to a study published in the April issue of The Journal of Urology.

Christopher Loftus, from the Lerner College of Medicine in Cleveland, and colleagues conducted a retrospective analysis of patients seen in the emergency department to examine the penetrance of medical expulsive therapy guideline recommendations. Data were included for 2,105 emergency department visits associated with an International Classification of Diseases, Ninth Revision diagnosis of urolithiasis, during which computerized tomography abdomen/pelvis scans were performed.

The researchers found that 48.8 percent of patients had ureteral stones, including 50 percent in whom medical expulsive therapy was prescribed. No significant difference was seen for patients who did and did not receive medical expulsive therapy. No difference was seen in the rate of urological procedures within 12 weeks of the initial emergency department visit or in the rate of return to the emergency department in patients who received medical expulsive therapy. A shorter time to spontaneous expulsion was seen for patients treated with medical expulsive therapy (7.1 versus 12.8 days; P = 0.048).

"Half of the patients who met criteria for medical expulsive therapy in this study did not receive the standard of care," the authors write. "These results highlight the need for personnel at emergency departments to better standardize care for patients with ureteral stones."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »